VistaGen Therapeutics Inc.

02/20/2026 | Press release | Distributed by Public on 02/20/2026 08:12

Management Change/Compensation (Form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers.
On February 13, 2026, Paul Edick resigned from the Board of Directors (the "Board") of Vistagen Therapeutics, Inc. (the "Company"). The Company is actively seeking new candidates to fill the resulting vacancy on the Board.
VistaGen Therapeutics Inc. published this content on February 20, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 20, 2026 at 14:12 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]